Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Peripheral T Cells Lymphoma (PTCL)”

167 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 167 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06550336
What this trial is testing

A Clinical Study Assessing the Efficacy of Chidamide for CD30-positive Peripheral T-cell Lymphoma (PTCL).

Who this might be right for
Peripheral T Cell Lymphoma
The First Hospital of Jilin University 35
Testing effectiveness (Phase 2)Study completedNCT00481871
What this trial is testing

Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies

Who this might be right for
Relapsed or Refractory Lymphoproliferative MalignanciesHodgkin's LymphomaPeripheral T-cell Lymphoma+2 more
Acrotech Biopharma Inc. 119
Testing effectiveness (Phase 2)Study completedNCT01611142
What this trial is testing

Study of KW-0761 (Mogamulizumab) in Subjects With Previously Treated Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
Peripheral T-Cell Lymphoma
Kyowa Kirin Co., Ltd. 38
Very early researchUnknownNCT04767308
What this trial is testing

Safety and Efficacy of CT125A Cells for Treatment of Relapsed/Refractory CD5+ Hematopoietic Malignancies

Who this might be right for
CD5+ Relapsed/Refractory Hematopoietic MalignanciesChronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)+3 more
Huazhong University of Science and Technology 18
Testing effectiveness (Phase 2)Ended earlyNCT04251065
What this trial is testing

Daratumumab Plus Gemcitabine, Dexamethasone, Cisplatin in pt R/R CD38+ PTCL-NOS, AITL and TFH

Who this might be right for
Refractory T-Cell LymphomaRelapsed T-Cell Lymphoma
Fondazione Italiana Linfomi - ETS 8
Testing effectiveness (Phase 2)UnknownNCT02533700
What this trial is testing

CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL

Who this might be right for
Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedAngioimmunoblastic T Cell LymphomaALK-negative Anaplastic Large Cell Lymphoma+3 more
Shandong Provincial Hospital 106
Testing effectiveness (Phase 2)Study completedNCT06511895
What this trial is testing

AZD4205 in Relapsed or Refractory Peripheral T Cell Lymphoma (JACKPOT27)

Who this might be right for
Peripheral T Cell Lymphoma
Dizal Pharmaceuticals 57
Large-scale testing (Phase 3)Not Yet RecruitingNCT06724237
What this trial is testing

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeFollicular Helper T-Cell LymphomaFollicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type+1 more
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Ended earlyNCT00972842
What this trial is testing

Lenalidomide, Vorinostat and Dexamethasone in Relapsed Patients With Peripheral T-Cell Non-Hodgkin's Lymphoma (PTCL)

Who this might be right for
Peripheral T-Cell Non-Hodgkin's Lymphoma
Arbeitsgemeinschaft medikamentoese Tumortherapie 20
Early research (Phase 1)Study completedNCT02567656
What this trial is testing

Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma

Who this might be right for
Lymphoma, T-Cell, PeripheralLymphoma, T-Cell, Cutaneous
Rhizen Pharmaceuticals SA 58
Testing effectiveness (Phase 2)UnknownNCT04052659
What this trial is testing

Sintilimab (IBI308) in Combination With Chidamide and Azacitidine in Refractory or Relapsed PTCL

Who this might be right for
Peripheral T-cell Lymphoma
Peking University 30
Early research (Phase 1)Study completedNCT01689220
What this trial is testing

SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) in Korea

Who this might be right for
Peripheral T-cell Lymphoma
Solasia Pharma K.K. 6
Testing effectiveness (Phase 2)Study completedNCT02953652
What this trial is testing

Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
Peripheral T-Cell Lymphoma (PTCL)
HUYABIO International, LLC. 55
Testing effectiveness (Phase 2)UnknownNCT04480125
What this trial is testing

Azacitidine Combined With Chidamide in the Treatment of Newly Diagnosed PTCL Unfit for Conventional Chemotherapy

Who this might be right for
Peripheral T-cell Lymphoma
Ruijin Hospital 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06757387
What this trial is testing

Chidamide Plus Golidocitinib in Relapsed/Refractory Peripheral T-Cell Lymphoma

Who this might be right for
Peripheral T-cell Lymphoma
Peking University Cancer Hospital & Institute 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT02223208
What this trial is testing

Ro Plus CHOEP as First Line Treatment Before HSCT in Young Patients With Nodal Peripheral T-cell Lymphomas

Who this might be right for
Peripheral T-cell Lymphomas (PTCL)PTCL-NOSAngioimmunoblastic T-cell Lymphoma (AITL)+2 more
Fondazione Italiana Linfomi - ETS 89
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07180771
What this trial is testing

Bosmolisib (BR101801) in Participants With R/R PTCL.

Who this might be right for
Peripheral T Cell Lymphoma
Boryung Pharmaceutical Co., Ltd 44
Testing effectiveness (Phase 2)Looking for participantsNCT06810778
What this trial is testing

Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
T-cell-prolymphocytic LeukemiaCutaneous T-Cell Lymphoma Refractory
Jonsson Comprehensive Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT00888927
What this trial is testing

Safety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T-Cell Lymphoma
Kyowa Kirin Co., Ltd. 42
Testing effectiveness (Phase 2)Ended earlyNCT05883449
What this trial is testing

Phase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCL

Who this might be right for
Relapsed or Refractory Hodgkin LymphomaPeripheral T Cell Lymphoma
Affimed GmbH 25
Load More Results
294